Zenas BioPharma, Inc. (ZBIO)
27.48
-2.16
(-7.27%)
USD |
NASDAQ |
Sep 24, 16:00
27.48
0.00 (0.00%)
After-Hours: 19:59
Zenas BioPharma Market Cap : 1.740B for Sept. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 23, 2026 | 1.876B |
| September 22, 2026 | 2.093B |
| September 21, 2026 | 2.061B |
| September 18, 2026 | 1.995B |
| September 17, 2026 | 2.025B |
| September 16, 2026 | 2.047B |
| September 15, 2026 | 2.022B |
| September 14, 2026 | 2.021B |
| September 11, 2026 | 1.971B |
| September 10, 2026 | 1.970B |
| September 09, 2026 | 2.045B |
| September 08, 2026 | 2.093B |
| September 04, 2026 | 2.082B |
| September 03, 2026 | 2.085B |
| September 02, 2026 | 2.098B |
| September 01, 2026 | 2.025B |
| August 31, 2026 | 2.047B |
| August 28, 2026 | 1.980B |
| August 27, 2026 | 2.066B |
| August 26, 2026 | 2.092B |
| August 25, 2026 | 2.139B |
| August 24, 2026 | 2.004B |
| August 21, 2026 | 2.045B |
| August 20, 2026 | 2.003B |
| August 19, 2026 | 1.979B |
| Date | Value |
|---|---|
| August 18, 2026 | 2.021B |
| August 17, 2026 | 1.932B |
| August 14, 2026 | 1.869B |
| August 13, 2026 | 1.849B |
| August 12, 2026 | 1.982B |
| August 11, 2026 | 2.054B |
| August 10, 2026 | 2.026B |
| August 07, 2026 | 2.023B |
| August 06, 2026 | 2.007B |
| August 05, 2026 | 1.988B |
| August 04, 2026 | 1.960B |
| August 03, 2026 | 1.942B |
| July 31, 2026 | 1.961B |
| July 30, 2026 | 2.013B |
| July 29, 2026 | 1.939B |
| July 28, 2026 | 2.014B |
| July 27, 2026 | 2.047B |
| July 24, 2026 | 1.896B |
| July 23, 2026 | 1.933B |
| July 22, 2026 | 1.964B |
| July 21, 2026 | 2.019B |
| July 20, 2026 | 1.915B |
| July 17, 2026 | 1.842B |
| July 16, 2026 | 1.762B |
| July 15, 2026 | 1.835B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.820B |
| Alnylam Pharmaceuticals, Inc. | 33.38B |
| Anika Therapeutics, Inc. | 271.41M |
| Savara, Inc. | 1.042B |
| Vericel Corp. | 2.011B |
Market Cap Related Metrics
| PS Ratio | 1424.51 |
| PEG Ratio | -0.0224 |
| Price to Book Value | 7.042 |
| Price | 27.48 |
| Earnings Yield | -35.00% |
| PEGY Ratio | -0.0224 |